Kennametal (KMT) Q1 2027 Earnings Call Transcript

Kennametal reported fiscal Q1 sales of $768 million, up 54% organically, and diluted EPS of $3.48 versus $0.30 a year earlier; results benefited substantially from favorable tungsten price-cost timing. Management maintained FY27 sales guidance at $3.35 billion to $3.45 billion and forecast adjusted EPS of $5.00 to $6.00, while noting expected tungsten-related headwinds later in the year. Free operating cash flow was negative $212 million as elevated tungsten costs increased working capital needs, and share repurchases remain paused; Infrastructure volume fell by a low double-digit percentage, partly offset by mid-single-digit Metal Cutting volume growth.

Analysis

The quarter’s headline profitability is a poor guide to near-term earning power: the price-versus-cost lag is doing much of the work, while cash is being committed to expensive inventory and supplier advances. As tungsten prices ease, the P&L benefit reverses before the balance sheet necessarily releases cash; lower replacement costs do not instantly monetize inventory bought at elevated prices. This creates a potential earnings-and-cash-flow air pocket, and the paused repurchase program is a consequence of that constraint rather than evidence that capital returns are imminent.

The main operating test is whether infrastructure can recover units without surrendering too much price. Customers facing unusually high tooling costs may substitute or redesign to use less tungsten; even successful recapture of current orders may therefore not restore prior material intensity. That is a structural demand risk, not just a quarter of delayed Chinese mining activity. Conversely, defense, aerospace and data-center power generation provide a better-quality growth mix, but current disclosures do not establish their consolidated profit or cash contribution.

Near term, a headline-driven rally risks discounting timing benefits that unwind later in FY27. Over 1–3 months, watch infrastructure volume and price realization alongside the Q3/Q4 price-cost drag. Over 6–18 months, the thesis depends on inventory efficiency, share gains and lean savings converting into cash and durable margins. The 16–19% EBITDA target is conditional on stable tungsten prices and execution; it should not be capitalized as already achieved. The contrarian upside is that normalized margins may be improving beneath the commodity noise, but cash conversion—not reported EPS—is the stronger confirmation signal.

Key Decisions for Investors

• Tactical relative-value idea: on post-earnings strength, consider short KMT versus long XLI over the next 1–3 months. The catalyst is fading price-raw support and an unfavorable second-half comparison; cap risk if tungsten stabilizes and infrastructure volume recovers faster than guided. Check borrow, valuation and spread volatility before sizing.
• Do not buy the reported earnings acceleration as a clean run-rate signal. Track quarterly EPS excluding price-raw timing, infrastructure unit volumes, and working capital as a percentage of sales; require improvement in cash conversion before expecting buybacks to resume.
• Treat positive cash-conversion evidence as the thesis falsifier: a sustained improvement in inventory turns and primary working capital, followed by positive free operating cash flow, would weaken the short. Persistent infrastructure declines or further price concessions would strengthen it.
• Monitor tungsten prices and procurement conditions, plus evidence of customer substitution or lower-tungsten product redesign. A renewed price spike could extend margin timing benefits but worsen liquidity; a faster decline could deepen the subsequent earnings headwind.